|
Jul 29
|
Revvity (RVTY) Q2 Earnings Beat Estimates, Guidance Revised
|
|
Jul 26
|
Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
|
|
Jul 26
|
3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now
|
|
Jul 26
|
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
|
|
Jul 26
|
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
|
|
Jul 26
|
Boston Scientific Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Jul 25
|
Boston Scientific's 'Solid' New 2024 Guidance Has Room for Upside, RBC Says
|
|
Jul 25
|
S&P 500’s Biggest Loser Has a Heart Valve Problem
|
|
Jul 25
|
Alphatec's (ATEC) New EOS Insight System to Boost Spine Care
|
|
Jul 25
|
Q2 2024 Boston Scientific Corp Earnings Call
|
|
Jul 24
|
Boston Sci Slumps After One Key Segment Drives Its Second-Quarter Beat
|
|
Jul 24
|
Boston Scientific Q2 Earnings: Strong Performance Of Cardiovascular Devices Leads To 2024 Guidance Hike Again
|
|
Jul 24
|
Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise
|
|
Jul 24
|
Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand
|
|
Jul 24
|
Veeva Systems' (VEEV) Vault EDC to Boost Vita Global's Workflow
|
|
Jul 24
|
Boston Scientific Raises Full-Year Outlook as Second-Quarter Results Beat Estimates
|
|
Jul 24
|
PacBio's (PACB) Revio System to Boost Novogene's German Lab
|
|
Jul 24
|
Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Jul 24
|
The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
|
|
Jul 24
|
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
|